Flugen INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersMadison, WI
US patents18
SAM.gov UEIM9FHAR3RBML5
CAGE code54YS4
Incorporated inWI
LEI5493002WPT70Z3ZMLE06
- vaccines
- respiratory disease
- potential application
- SARS-CoV-2
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
18 US patents granted 2010–2025, 9 of them in the five years to SEP 2025, including 2 design patents.
Pharmaceuticals 15Medical technology 1
- Influenza b virus mutants and uses thereforUS 12,390,519 · granted AUG 19, 2025
- Immunogenic compositions against influenzaUS 12,311,020 · granted MAY 27, 2025
- Influenza virus vectors and uses thereforUS 11,980,662 · granted MAY 14, 2024
- Influenza virus mutants and uses thereforUS 11,980,661 · granted MAY 14, 2024
- Influenza B virus mutants and uses thereforUS 11,529,409 · granted DEC 20, 2022
Newest 5 shown · Granted to FluGen, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Flugen INC | Madison | WI | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.